Sign in
Not yet recruitingNo phase

Cross-linked donor corneas for keratoconus surgery with deep lamellar keratoplasty

Tests cross-linked donor corneas in adults with keratoconus having deep lamellar keratoplasty.

Key facts

Who runs it
Zhongshan Ophthalmic Center, Sun Yat-sen University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Donors Predisposed by Corneal Collagen Cross-linking in Deep Lamellar Keratoplasty for the Patients With Keratoconus
Status
Not yet recruiting
People taking part
70 people, planned
Started
Jun 2023
Expected to end
Jul 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Corneal donors predisposed by CXL
  • Corneal donors stored in corneal storage media
Record updated
15 June 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with keratoconus who need a deep lamellar cornea transplant (DALK). It compares donor corneas pre-treated with cross-linking (CXL) to usual stored donor corneas.

Age
18 to 70 Years
Sex
All sexes can join.
Disease stage
Advanced keratoconus. At least one of these: vision with glasses at its clearest is less than 0.3; vision with rigid gas permeable contact lenses at its clearest is less than 0.5, or these lenses cannot be tolerated; front corneal curvature >55D; thinnest cornea less than 400 μm.
Earlier treatment
People who had surgery inside the eye before cannot join.

Main reasons for not taking part

  • Past surgery inside the eye
  • Severe dry eye
  • Severe scars of the eyelid or the conjunctiva (the clear layer covering the eye white)
  • Vision lost in the other eye
  • Pregnant or breastfeeding women

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 1.The best corrected visual quality of frame glasses is less than 0.3,2.The best corrected visual quality of rigid gas permeable contact lens (RGPCL) is less than 0.5/ RGPCL intolerance,3.The anterior corneal surface curvature >55D,4.The thinnest corneal thickness is less than 400 μm. One of the above four items is met
  • Patients must be willing and able to return for scheduled follow-up examinations for 36 months after surgery
  • Ages:over 18 Years

Who cannot take part

  • History of intraocular surgery
  • Severe dry eye
  • Severe eyelid and conjunctival scar
  • Loss of vision in contralateral eye
  • Pregnant and lactating women

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The Study was designed as a randomized controlled study with the following objectives:

Read full original descriptionShow less

To investigate whether use of donors predisposed by corneal collagen cross-linking (CXL) reduced myopic refractive errors for keratoconic eyes after Deep anterior lamellar keratoplasty (DALK).

Overall 70 patients are planned to recruit., the patients were assigned to CXL graft group, in which corneal donors predisposed by CXL were used, or the conventional graft group, in which corneal donors stored in corneal storage media were used. The patients will be followed-up for 24 months.

The 2 groups in the trial

  • CXL graft groupTreatment being tested

    Corneal donors predisposed by CXL were used and the conventional DALK procedure was conducted in patients

    Treatment: Corneal donors predisposed by CXL

  • Conventional graft groupExisting treatment, for comparison

    Corneal donors stored in corneal storage media were used and the conventional DALK procedure was conducted in patients

    Treatment: Corneal donors stored in corneal storage media

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness and Safety of Donors Predisposed by Corneal Collagen Cross-linking in Deep Lamellar Keratoplasty for Treating the Patients With Keratoconus,A Randomized Controlled Trial.
Plain-language title
Cross-linked donor corneas for keratoconus surgery with deep lamellar keratoplastyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT05905978, who can take part
Record updated
15 June 2023